AFA
ABBV icon

Alpha Financial Advisors’s AbbVie ABBV Stock Holding History

Alpha Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$242K Sell
963
-22
-2% -$4.73K 0.06% 84
2026
Q1 		$214K Buy
985
+101
+11% +$22.4K 0.07% 61
2025
Q4 		$202K Sell
884
-12
-1% -$2.73K 0.06% 67
2025
Q3 		$208K Buy
+896
New +$182K 0.07% 62

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Alpha Financial Advisors's ABBV Position: Q2 2026 in Review

Alpha Financial Advisors reduced its AbbVie (ABBV) stake by 2.2% in Q2 2026, selling an estimated $4.73K and leaving 963 shares worth $242K. The position accounts for 0.06% of the portfolio, ranked #84.

Alpha Financial Advisors first reported a position in ABBV in Q3 2025 and has held it in 4 quarters since. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Alpha Financial Advisors held 963 shares of AbbVie worth $242K as of Q2 2026.
  • Alpha Financial Advisors sold 22 AbbVie shares in Q2 2026, an estimated $4.73K.
  • AbbVie made up 0.06% of Alpha Financial Advisors's portfolio in Q2 2026, its #84 holding.
  • Alpha Financial Advisors first reported a position in AbbVie in Q3 2025 and has held it in 4 quarters since.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Alpha Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.